GPs are a major part a new treatment that can eliminate hepatitis C in Australia, but more patients need to be identified to achieve the best results.Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
Hundreds of thousands of Australians with hepatitis C are failing to access new curative drugs, despite the Government subsidising them at huge cost to the taxpayer.
The trend means the Government is at risk of missing its target to eradicate hepatitis C and of spending far more than necessary on the treatments.Read More
Australia will not achieve the goal of eradicating hepatitis C without further action to ensure patients are identified and treated.
Speaking with PharmaDispatch following her appointment as president of Hepatitis Australia, Felicity McNeill PSM, said so much positive work has been done, with thousands of people cured, but all stakeholders must come together to address the fact treatment rates are in decline.Read More
Someone very familiar to the pharmaceutical sector has been appointed president of Hepatitis Australia. Felicity McNeill PSM, who for almost five years served as first assistant secretary of the Pharmaceutical Benefits Division, has been appointed to the part-time role of president of the national peak body focussed on representing Australians living with hepatitis B and C.Read More
After three days of discussing, debating and formulating solutions together, the World Hepatitis Summit 2017 drew to a close on Friday. Over 900 delegates from 110 countries descended on São Paulo, Brazil all armed with one goal: the elimination of viral hepatitis. At the event, double the size of the inaugural World Hepatitis Summit 2015, important steps were made to reach this goal by 2030.Read More